Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01555 |
| Species: | Homo sapiens |
| Position : | chr20:43657287-43657942 |
| Year: | 2023 |
| Title: | eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | esophageal adenocarcinoma |
| PMID: | 36803948 |
| MONDO: | MONDO:0004973 |
| Tissue: | Esophagus |
| Tissue Ontology ID: | UBERON:0001043 |
| Cell Source: | CP-A |
| CVCL ID: | CVCL_6920 |
| Cell Type: | esophageal adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ATAC-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR knockout/CRISPRi, RT-RT-qPCR, Western blot |
| Target gene : | MYBL2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01554 | chr20:43657287-43657942 | Esophagus | esophageal adenocarcinoma cell | esophageal adenocarcinoma |